InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,463.54
(
0.08%
)
US TECH 100
18,493.20
(
-0.14%
)
Dow Jones
40,539.93
(
-0.12%
)
Brent Oil
78.67
(
-0.61%
)
Bitcoin
66,601.57
(
-0.33%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GetSeriousOK

Send PM Follow Ignore
Followers 37
Posts 7142
Boards Moderated 1
Alias Born 09/06/2014

GetSeriousOK

Re: dcspka post# 25544

Thursday, 10/09/2014 8:38:02 AM

Thursday, October 09, 2014 8:38:02 AM

Post# of 30046
There is no Provista/Radient connection currently.

There was a connection in 2009-2011. Then Provista got smart.

Provista's breast cancer test detects proteins that are specific to breast cancer. Adding DR-70 to that would eliminate the benefit of the test -- it would no longer be specific to breast cancer.

But even if Provista wanted to combine DR-70 with another test, they could do so without buying, merging with, or taking over Radient because DR-70 is off patent. Anyone can manufacture and sell DR-70 now without paying a dime to Radient.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up